Yanan Zhu

Q: What is Yanan Zhu's success rate?

Yanan Zhu currently has a success rate of 88.60154659988865.

Q: What is the average return of Yanan Zhu's calls?

Their stock ratings have generated an average return of 61.5108577627485.

Wells Fargo | Healthcare

Yanan Zhu is an analyst from Wells Fargo specializing in the Healthcare sector. Ranked #237 out of 4559 analysts, they have issued 39 stock ratings with a success rate of 88.60% and an average return of 61.51%.

Yanan Zhu has a well-established track record, with 39 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 88.60% and an average return of 61.51%, underscoring their expertise and ability to identify winning opportunities for investors.

#237

Out of 4559

Total Ratings

+88.60%

Success Rate

+61.51%

Average Return

Recent Ratings Analysis

NTLA

Hold

Mar 03, 2026

Target

$15.00

Current

$13.61

Performance

-0.04%

Yanan Zhu rated NTLA as Equal-Weight on Mar 03, 2026, setting a price target of 15. The Hold stance appears justified, as shares hovered around 13.605 with a -0.04% move.

QURE

Hold

Mar 03, 2026

Target

$60.00

Current

$9.03

Performance

0.00%

On Mar 03, 2026, QURE was given a Equal-Weight rating by Yanan Zhu, with a target price of 60. Market indecision, reflected in sideways trading near 9.03, supported the cautious call.

SRPT

Buy

Feb 27, 2026

Target

$45.00

Current

$15.87

Performance

-5.31%

SRPT received a Overweight rating from Yanan Zhu on Feb 27, 2026, aiming for 45. The rating hasn’t played out as hoped, with the stock trading 5.31% below expectations.

ACLX

Hold

Feb 23, 2026

Target

$115.00

Current

$114.05

Performance

0.26%

On Feb 23, 2026, Yanan Zhu published a Equal-Weight outlook on ACLX, with a target of 115. Sideways action left the Hold view intact, with no major move since 114.05.

SYRE

Buy

Feb 20, 2026

Target

$50.00

Current

$40.07

Performance

-7.27%

Yanan Zhu on Feb 20, 2026 assigned SYRE a Overweight rating, with a price target of 50. The call has struggled to gain traction, with shares losing 7.27%.

RAPT

Hold

Jan 20, 2026

Target

$58.00

Current

$58.02

Performance

0.78%

On Jan 20, 2026, Yanan Zhu reaffirmed RAPT with a Equal-Weight rating, targeting 58. The neutral call matched muted market action of 0.78%.

IONS

Buy

Jan 05, 2026

Target

$100.00

Current

$78.66

Performance

0.17%

IONS was rated Overweight by Yanan Zhu on Jan 05, 2026, with a price objective of 100. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

TSHA

Buy

Jan 05, 2026

Target

$11.00

Current

$4.53

Performance

-7.36%

On Jan 05, 2026, Yanan Zhu initiated coverage on TSHA with a Overweight rating and target of 11. The Buy call has yet to be validated as shares remain 6.47 away from the target.

ARCT

Buy

Oct 23, 2025

Target

$20.00

Current

$7.91

Performance

-34.08%

Yanan Zhu issued a Overweight recommendation for ARCT on Oct 23, 2025, price target set at 20. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

EDIT

Hold

Sep 03, 2025

Target

$4.00

Current

$2.04

Performance

-18.40%

On Sep 03, 2025, EDIT was evaluated by Yanan Zhu, who gave a Equal-Weight rating and target of 4. The Hold call avoided chasing into subsequent weakness of 18.40%.

NAMS

Buy

Aug 25, 2025

Target

$45.00

Current

$30.41

Performance

23.10%

Yanan Zhu rated NAMS as Overweight on Aug 25, 2025, setting a price target of 45. The call has proven timely, with shares rising 23.10% toward the price target of 45.

MGX

Buy

Aug 14, 2025

Target

$12.00

Current

$1.51

Performance

-20.53%

On Aug 14, 2025, MGX was given a Overweight rating by Yanan Zhu, with a target price of 12. Despite the Buy call, shares fell from 1.51 to 1.51, challenging the optimistic stance.

FATE

Hold

Aug 13, 2025

Target

$2.50

Current

$1.37

Performance

21.24%

FATE received a Equal-Weight rating from Yanan Zhu on Aug 13, 2025, aiming for 2.5. Investors saw gains of 21.24% that the cautious stance didn’t fully capture.

AUTL

Buy

Aug 13, 2025

Target

$5.00

Current

$1.62

Performance

-11.96%

On Aug 13, 2025, Yanan Zhu published a Overweight outlook on AUTL, with a target of 5. Market action contradicted the Buy thesis, as shares slipped to 1.62.

RNA

Buy

Aug 08, 2025

Target

$75.00

Current

$15.67

Performance

-66.15%

Yanan Zhu on Aug 08, 2025 assigned RNA a Overweight rating, with a price target of 75. The call has struggled to gain traction, with shares losing 66.15%.

IOVA

Buy

Aug 08, 2025

Target

$14.00

Current

$3.75

Performance

77.49%

On Aug 08, 2025, Yanan Zhu reaffirmed IOVA with a Overweight rating, targeting 14. The recommendation was supported by strong follow-through as the stock rose from 3.745 to 3.745.

AFMD

Hold

May 13, 2025

Target

$0.10

Current

$0.18

Performance

35.45%

AFMD was rated Equal-Weight by Yanan Zhu on May 13, 2025, with a price objective of 0.1. Despite caution, upside momentum rewarded risk-takers with gains to 0.1815.

RGLS

Buy

Mar 27, 2025

Target

$6.00

Current

$8.16

Performance

444.00%

On Mar 27, 2025, Yanan Zhu initiated coverage on RGLS with a Overweight rating and target of 6. The stock’s climb of 444.00% since the call highlights the foresight in the rating.

ADAP

Hold

Mar 21, 2025

Target

$1.50

Current

$0.05

Performance

-83.32%

Yanan Zhu issued a Equal-Weight recommendation for ADAP on Mar 21, 2025, price target set at 1.5. Market action validated the conservative Hold outlook with shares at 0.0485.

VYGR

Buy

Mar 12, 2025

Target

$10.00

Current

$4.07

Performance

0.25%

On Mar 12, 2025, VYGR was evaluated by Yanan Zhu, who gave a Overweight rating and target of 10. So far, the Buy call awaits clearer momentum, with shares flat at 4.07.

BLUE

Hold

Feb 24, 2025

Target

$5.00

Current

$4.97

Performance

22.72%

Yanan Zhu rated BLUE as Equal-Weight on Feb 24, 2025, setting a price target of 5. Despite the Hold call, shares climbed 22.72% to 4.97, revealing unexpected momentum.

CRSP

Hold

May 09, 2024

Target

$65.00

Current

$58.06

Performance

8.42%

On May 09, 2024, CRSP was given a Equal-Weight rating by Yanan Zhu, with a target price of 65. The stock rallied from 58.06 to 58.06 after the Hold rating, surprising to the upside.

Frequency Asked Questions

Who is Yanan Zhu?

Yanan Zhu is an analyst from Wells Fargo specializing in the Healthcare sector.

What is Yanan Zhu's success rate?

Yanan Zhu currently has a success rate of +88.60%.

How many ratings has Yanan Zhu issued?

Yanan Zhu has issued 39 stock ratings so far.

What is the average return of Yanan Zhu's calls?

Their stock ratings have generated an average return of +61.51%.

What is Yanan Zhu's ranking?

Yanan Zhu is ranked #237 out of 4559 analysts.

What types of ratings does Yanan Zhu give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Yanan Zhu?

You can follow Yanan Zhu by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Yanan Zhu?

Their latest rating was a Hold on NTLA issued on 2026-03-03.